Stay updated on Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial page.

Latest updates to the Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange Detected- The update changes only the page revision label from v3.4.1 to v3.4.2 and does not affect core study information or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check22 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; this is a metadata update with no changes to core content, study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4 appears in the page footer. No substantive changes to the study content or layout are detected.SummaryDifference0.1%

- Check66 days agoChange DetectedAdded a Locations section listing New York and Ohio as study sites; this consolidates the prior New York Locations and Ohio Locations entries. The page revision was updated to v3.3.3 and the HHS Vulnerability Disclosure link was removed from the footer.SummaryDifference0.3%

- Check95 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2. No visible changes to the study details or page behavior.SummaryDifference0.1%

- Check102 days agoChange DetectedThe funding-status banner regarding government operations has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cetuximab and Pembrolizumab in Colorectal Cancer Clinical Trial page.